Takeda Pharmaceutical Co Ltd
TAK· NYSE
Takeda Pharmaceutical Co Ltd
- Last sale
- Oct 2, 2026 · -0.11%
- Market cap
- —
- no share count on file
- Filings
- 704
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-03-31 | ¥4,505,720,000,000 | reported | |
| FY 2025 | 2025-03-31 | ¥4,581,551,000,000 | reported | |
| FY 2024 | 2024-03-31 | ¥4,263,762,000,000 | reported | |
| FY 2023 | 2023-03-31 | ¥4,027,478,000,000 | reported | |
| FY 2022 | 2022-03-31 | ¥3,569,006,000,000 | reported | |
| FY 2021 | 2021-03-31 | ¥3,197,812,000,000 | reported | |
| FY 2020 | 2020-03-31 | ¥3,291,188,000,000 | reported | |
| FY 2019 | 2019-03-31 | ¥2,097,224,000,000 | reported | |
| FY 2018 | 2018-03-31 | ¥1,770,531,000,000 | reported | |
| FY 2017 | 2017-03-31 | ¥1,732,051,000,000 | reported |
Takeda Pharmaceutical Co Ltd · CIK 1395064 · Engraved from SEC EDGAR
